Texas Instruments Incorporated (NASDAQ: TXN), headquartered in Dallas, Texas, is preparing to report its financial results for the fourth quarter following the closing bell on Tuesday, January 27, 2026. Current consensus estimates reflect expectations for the company to deliver earnings per share (EPS) of $1.31, representing a narrow increase over the EPS of $1.30 reported in the same quarter of the previous year.
On the revenue front, analysts foresee an upward trend, with projections settling at approximately $4.44 billion for the quarter, compared to $4.01 billion recorded in the corresponding 2025 period. This anticipated growth signals continued demand within Texas Instruments’ semiconductor segments.
Earlier in the fiscal year, on October 21, Texas Instruments disclosed third-quarter revenues totaling $4.74 billion. This figure surpassed the analyst consensus which had expected $4.65 billion, illustrating the company’s ability to outperform market expectations.
Investor confidence appears somewhat buoyant, as shares of Texas Instruments closed at $196.59 on Monday, January 26, reflecting a 1.7% gain ahead of the earnings announcement.
Against this backdrop, a review of forward-looking analyst opinions from some of the most precise market observers provides insight into the expectations for Texas Instruments.
- Susquehanna’s Christopher Rolland has maintained a Positive rating on TXN, signaling a strong recommendation for the stock. On January 22, 2026, Rolland increased his price target from $200 to $225, underpinning his optimistic outlook. His analyst accuracy stands at 78%, lending credibility to his assessment.
- Stifel’s Tore Svanberg continues to rate the stock as Hold. However, on January 16, 2026, Svanberg raised his price target notably from $170 to $200. His opinions are backed by an 82% accuracy rate in prior forecasts.
- Wells Fargo analyst Joe Quatrochi also maintains an Equal-Weight rating, a cautious stance compared to some peers. On January 15, 2026, Quatrochi raised the price target from $170 to $185, indicating moderate confidence. His historical accuracy stands at 55%.
- Truist Securities’ William Stein rates Texas Instruments with a Hold recommendation as well. On December 19, 2025, he revised the price target upward to $195 from $175. Stein’s forecasting accuracy is relatively high at 87%.
- Goldman Sachs analyst James Schneider took a contrasting view by downgrading the stock from Buy to Sell on December 15, 2025. Alongside this shift, Schneider cut the price target markedly from $200 to $156. His analyst accuracy is listed at 65%.
The diversity in analyst opinions reflects a wide range of interpretations of the company’s prospects as it approaches its quarterly earnings disclosure. The mix of increased price targets alongside retained Hold positions suggests cautious optimism, whereas the recent downgrade from Goldman Sachs points to concerns that warrant attention.
Market participants and readers looking to explore detailed analyst ratings are encouraged to consult dedicated stock rating resources, which allow sorting by stock ticker, analyst firm, rating changes, and more, facilitating comprehensive investment research.
Texas Instruments’ recent share performance and the adjustments in analyst price targets capture an evolving outlook that is sensitive to quarterly results and broader semiconductor industry dynamics. Monitoring the upcoming Q4 earnings release will provide investors a clearer window into the company’s immediate trajectory amid shifts in demand and supply factors.
While no new guidance or forecasts beyond these analyst adjustments are available ahead of the report, the anticipation builds as the market digests previous earnings beats and the incremental price target revisions.